King Steven R. 4

What Happened
Steven R. King, Chief of Sustainable Supply, Ethnobotanical Research and Intellectual Property and Secretary of Jaguar Health (JAGX), received equity awards on December 11, 2025: 11,740 restricted stock units (RSUs) and a derivative award (an option covering 11,740 shares). Both awards were granted at $0.00 (no cash outlay by the insider). The awards were approved by the issuer’s board under the 2014 Stock Incentive Plan.

Key Details

• Transaction date: December 11, 2025; Form 4 filed January 21, 2026 (filed late relative to the 2-business-day Form 4 deadline).
• Awards: 11,740 RSUs (granted) and a derivative grant for 11,740 shares (options) — both reported at $0.00.
• Vesting: RSUs vest on December 11, 2026 (each RSU converts to one common share on vesting). Options vest ratably each month over 12 months from the grant date, subject to continued employment.
• Plan and approval: Grants made pursuant to the issuer’s 2014 Stock Incentive Plan and approved by the board on Dec 11, 2025.
• Shares owned after transaction: Not stated in the filing.

Context
These awards are grants (not open-market purchases or sales) and therefore are routine compensation rather than an immediate bullish or bearish trading signal. RSUs convert to shares only on the vesting date (Dec 11, 2026), and the option tranche vests monthly over a year before it can be exercised according to the filing. The late filing reduces timely disclosure to the market but does not by itself indicate the nature of the insider’s intentions.